Becton, Dickinson and Company (VIE:BDX)

Market Cap	47.59B
Revenue (ttm)	18.61B
Net Income (ttm)	1.43B
Shares Out	n/a
EPS (ttm)	4.96
PE Ratio	33.27
Forward PE	12.93
Dividend	3.74 (2.26%)
Ex-Dividend Date	Sep 8, 2025

Volume	n/a
Average Volume	n/a
Open	166.15
Previous Close	164.90
Day's Range	165.50 - 166.15
52-Week Range	141.45 - 242.90
Beta	n/a
RSI	54.33
Earnings Date	Feb 5, 2026

About VIE:BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BDX

Financial Performance

In 2025, VIE:BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD